Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Tempe, Arizona 85283


Purpose:

The purpose of this research is to evaluate the safety and pharmacokinetic profile of single doses of ATX-101


Study summary:

This is a single center, open-label, dose-escalation study in which subjects will receive 4 different dosage concentrations (3 dosing paradigms) of ATX-101 in a single dosing session.


Criteria:

Inclusion Criteria: - Healthy males or nonpregnant females - Age 18 to 65 - Sufficient submental fat for injections - Signed informed consent Exclusion Criteria: - Prior interventions in the chin or neck area - History or presence of drug or alcohol abuse - Treatment with an investigational agent within 30 days before the dose


NCT ID:

NCT00618709


Primary Contact:

Principal Investigator
Dennis Swearingin, M.D.
MDS Pharma Services


Backup Contact:

N/A


Location Contact:

Tempe, Arizona 85283
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.